Moser Asher M, Urkin Jacob, Shalev Hanna
Department of Pediatric Hematology/Oncology, Soroka Medical Center, Ben-Gurion University of the Negev, Be'er Sheva, Israel.
J Pediatr Hematol Oncol. 2011 Aug;33(6):467-9. doi: 10.1097/MPH.0b013e31821c629f.
Iron deficiency anemia (IDA) is the most common hematologic disorder worldwide. Measures to prevent IDA in infants have been successful with questionable sustainability.
To evaluate the incidence of developing IDA in the second year of life, in infants who were nonanemic at the age of 1 year on routine blood test.
Blood samples were obtained from 193, 24-month-old toddlers, from 2 large clinics of both main sectors in Southern Israel, comparable for lower economic status. IDA was defined as hemoglobin < 11 gr% and microcytosis as mean corpuscular volume < 70 fL.
IDA was detected in 8 of 118 Bedouins (5 males) and in 10 of 75 Jewish (6 males) infants (P < 0.01). The probability of a nonanemic child to develop IDA in the second year of life for the whole study population was 9.3% (18 of 193 infants) and significantly higher in the Jewish population (13.3.0% vs. 6.8%, P < 0.01).
Given the difficulty of toddlers to maintain a non-IDA status, and the very low probability of iron overload, our results clearly support the need to continue iron supplementation into the second year.
缺铁性贫血(IDA)是全球最常见的血液系统疾病。预防婴儿缺铁性贫血的措施虽已取得成功,但可持续性存疑。
评估1岁时血常规检查无贫血的婴儿在生命第二年发生缺铁性贫血的发生率。
从以色列南部两个主要地区的2家大型诊所选取193名24个月大的幼儿采集血样,这些幼儿经济地位较低且具有可比性。缺铁性贫血定义为血红蛋白<11g%,小红细胞症定义为平均红细胞体积<70fL。
118名贝都因婴儿中有8名(5名男性)以及75名犹太婴儿中有10名(6名男性)检测出缺铁性贫血(P<0.01)。整个研究人群中,1岁时无贫血的儿童在生命第二年发生缺铁性贫血的概率为9.3%(193名婴儿中有18名),在犹太人群中显著更高(13.3%对6.8%,P<0.01)。
鉴于幼儿维持非缺铁性贫血状态存在困难,且铁过载的可能性极低,我们的结果明确支持在生命第二年继续补充铁剂的必要性。